BD Expands Efforts to Combat Antimicrobial Resistance with New Automated ID/AST System

New BD Phoenix™ M50 System delivers modularity, reliability, affordability, and high-quality susceptibility results needed by clinical microbiology laboratories worldwide

| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

FRANKLIN LAKES, N.J. – BD (Becton, Dickinson, and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation diagnostic instrument for the rapid identification of bacteria and detection of antimicrobial resistance.

The global health care community is facing unprecedented challenges with the spread of multidrug resistant organisms, and today’s clinical microbiology laboratories are under increasing pressure to provide fast and accurate bacterial identification and antimicrobial susceptibility testing  (ID/AST) results to influence clinical decision and outcomes.

Lab manager academy logo

Get training in Biosafety and Biosecurity and earn CEUs.

One of over 25 IACET-accredited courses in the Academy.

Certification logo

Biosafety and Biosecurity course

The new BD Phoenix™ M50 ID/AST system helps deliver the same rapid, accurate and cost-effective testing as the legacy BD Phoenix™ 100, within a smaller footprint. The system is highly reliable and requires no preventative maintenance, thanks to innovative materials and engineering techniques employed during its development.  In addition to being robust, the system offers multiple languages, facilitating even broader adoption in laboratories around the world.

The new system benefits from the demonstrated performance of the legacy BD Phoenix 100 system for detecting current and emerging resistances as well as the extended testing capabilities provided by BD Phoenix™ Emerge AST panel with 136 wells.

The BD Phoenix M50 system also offers integration with multiple other analyzers, including the BD BACTEC™ and BD Bruker™ MALDI Biotyper systems, through BD EpiCenter™ middleware connectivity that enables data traceability and security, paperless workflow and flexible communication capabilities to deliver the efficiencies expected by laboratories of all sizes.  The BD Phoenix M50 system joins the overall BD diagnostics portfolio to help drive the transformation of microbiology.

“The small footprint of the BD Phoenix M50 system combined with its demonstrated speed, accuracy and efficiency makes the system an attractive solution for microbiology laboratories around the world,” said Dave Hickey, president of Diagnostics Systems for BD. “This launch reinforces the engagement of BD to become more relevant in ID/AST and intensifies its support to the fight against antimicrobial resistance.”

Visit bd.com/ds for more information.

Interested in life sciences?

Subscribe to our free Life Sciences Newsletter.

Is the form not loading? If you use an ad blocker or browser privacy features, try turning them off and refresh the page.

Loading Next Article...
Loading Next Article...

CURRENT ISSUE - January/February 2025

Energizing Leadership in Action

The science-backed behaviors that help leaders inspire thriving teams and organizations

Lab Manager January/February 2025 Cover Image